Trial intelligence / Profile preview

Socket Augmentation Using Atorvastatin and Platelet Concentrates

NCT03231137Phase 4Completed

Sponsor
Ain Shams University
Start
Jun 2012
Primary completion
Mar 2017
Modality
Small Molecules
01

Overview

Phase 4, randomised trial of atorvastatin 1.2% gel in Alveolar ridge resorption (5 arms), sponsored by Ain Shams University. Primary endpoints: Relative ridge height at 2 months and Ridge width at 2 months. Started Jun 2012; status: completed.

02

Drugs

atorvastatin 1.2% gel
03

Conditions

Alveolar ridge resorption

Beyond the preview

Go deeper on NCT03231137.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03231137.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call